Bioorganic and Medicinal Chemistry Letters p. 163 - 168 (1997)
Update date:2022-08-03
Topics:
Cherney, Robert J.
Swartz, Stephen G.
Patten, Arthur D.
Akamike, Emeka
Sun, Jung-Hui
Kaltenbach III, Robert F.
Seitz, Steven P.
Behrens, Carl H.
Getahun, Zelleka
Trainor, George L.
Vavala, Mike
Kirshenbaum, Mindy R.
Papp, Lisa M.
Stafford, Margaret P.
Czerniak, Philip M.
Diamond, Richard J.
McRipley, Ronald J.
Page, Roni J.
Gross, Janet L.
Unsymmetrical bis-imides 1 were synthesized and evaluated as potential antitumor agents. These novel bis-imides were assessed using three criteria: in vitro cytotoxicity (L1210), in vitro DNA binding, and in vivo studies with human tumor xenografts in mice. These studies identified DMP 315 as a potent, water soluble antitumor agent.
View MoreChemtrade International ( China )
Contact:+86-532-86893005
Address:Rm 2-501, Huaxia Zonghe Building, No. 410 JInggangshan Road, Huangdao
Shanghai AoBo Bio-Pharmaceutical Technology Co., Ltd.
Contact:+86-21-51320130-801, 816
Address:Room 601, No. 1011, Halei Road, Zhangjiang High-Tech Park, Pudong, Shanghai
Contact:+31-24-3886056
Address:Binderskampweg 29 Unit 36
website:http://www.mascot-ie.com
Contact:86-519-85010339
Address:B-802,XingBei Building,391#,Tongjiang Middle Road New District,Changzhou,JS,China
CHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD
website:http://www.czyys.com
Contact:0086-519-88802789
Address:No.300,Yanling Middle Road, Changzhou, Jiangsu, China
Doi:10.1021/ja00512a045
(1979)Doi:10.13005/ojc/310168
(2015)Doi:10.1039/P19790001729
(1979)Doi:10.1021/ja01500a026
(1960)Doi:10.1007/s11164-015-2373-y
(2016)Doi:10.1016/S0040-4039(01)80784-X
(1989)